Pacira BioSciences, Inc.

Pacira BioSciences, Inc.verified

PCRX

Price:

$29.69

Market Cap:

$1.38B

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira Bi...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2011-02-03

Stock Exchange

NASDAQ

Ticker

PCRX

The PE Ratio as of May 2024 (TTM) for Pacira BioSciences, Inc. (PCRX) is 19.66

According to Pacira BioSciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 19.66. This represents a change of -24.53% compared to the average of 26.05 of the last 4 quarters.

Pacira BioSciences, Inc. (PCRX) Historical PE Ratio (quarterly & annually)

How has PCRX PE Ratio performed in the past?

The mean historical PE Ratio of Pacira BioSciences, Inc. over the last ten years is -246.86. The current 19.66 PE Ratio has changed -896.39% with respect to the historical average. Over the past ten years (40 quarters), PCRX's PE Ratio was at its highest in in the June 2015 quarter at 80.62K. The PE Ratio was at its lowest in in the September 2022 quarter at -879.42.

Quarterly (TTM)
Annual

Average

-246.86

Median

-7.06

Minimum

-3736.71

Maximum

1.51K

Pacira BioSciences, Inc. (PCRX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Pacira BioSciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 8.66%

Maximum Annual PE Ratio = 1.51K

Minimum Annual Increase = -765.02%

Minimum Annual PE Ratio = -3736.71

Quarterly (TTM)
Annual
YearPE RatioChange
202337.17-66.35%
2022110.4874.14%
202163.44261.56%
202017.55-110.28%
2019-170.71-95.43%
2018-3736.718.66%
2017-42.6434.67%
2016-31.67-102.09%
20151.51K-765.02%
2014-227.33663.18%

Pacira BioSciences, Inc. (PCRX) Average PE Ratio

How has PCRX PE Ratio performed in the past?

The current PE Ratio of Pacira BioSciences, Inc. (PCRX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

70.36

5-year avg

11.59

10-year avg

-246.86

Pacira BioSciences, Inc. (PCRX) PE Ratio vs. Peers

How is PCRX’s PE Ratio compared to its peers?

Pacira BioSciences, Inc.’s PE Ratio is less than Phibro Animal Health Corporation (57.02), greater than Dr. Reddy's Laboratories Limited (17.27), greater than Collegium Pharmaceutical, Inc. (11.87), greater than Silver Spike Investment Corp. (14.18), greater than Prestige Consumer Healthcare Inc. (15.23), less than HUTCHMED (China) Limited (158.42), greater than Incannex Healthcare Limited (-2.24), greater than Eagle Pharmaceuticals, Inc. (2.57), less than ANI Pharmaceuticals, Inc. (32.95), greater than Deciphera Pharmaceuticals, Inc. (-11.71), greater than Intra-Cellular Therapies, Inc. (-57.27), greater than Alkermes plc (9.29),

Build a custom stock screener for Pacira BioSciences, Inc. (PCRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pacira BioSciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pacira BioSciences, Inc. (PCRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pacira BioSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Pacira BioSciences, Inc.'s PE Ratio?

How is the PE Ratio calculated for Pacira BioSciences, Inc. (PCRX)?

What is the highest PE Ratio for Pacira BioSciences, Inc. (PCRX)?

What is the 3-year average PE Ratio for Pacira BioSciences, Inc. (PCRX)?

What is the 5-year average PE Ratio for Pacira BioSciences, Inc. (PCRX)?

How does the current PE Ratio for Pacira BioSciences, Inc. (PCRX) compare to its historical average?